| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A common coding variant in CASP8 is associated with breast cancer risk.
|
Nat Genet
|
2007
|
7.35
|
|
2
|
Heritability of mammographic density, a risk factor for breast cancer.
|
N Engl J Med
|
2002
|
6.19
|
|
3
|
Cancer incidence before and after kidney transplantation.
|
JAMA
|
2006
|
4.77
|
|
4
|
Dominant negative ATM mutations in breast cancer families.
|
J Natl Cancer Inst
|
2002
|
3.46
|
|
5
|
Familial risks, early-onset breast cancer, and BRCA1 and BRCA2 germline mutations.
|
J Natl Cancer Inst
|
2003
|
2.84
|
|
6
|
Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry.
|
J Clin Oncol
|
2005
|
2.70
|
|
7
|
A genome wide linkage search for breast cancer susceptibility genes.
|
Genes Chromosomes Cancer
|
2006
|
2.35
|
|
8
|
Obesity and outcomes in premenopausal and postmenopausal breast cancer.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
2.14
|
|
9
|
Comparison of cancer mortality and incidence in New Zealand and Australia.
|
N Z Med J
|
2002
|
1.94
|
|
10
|
Cancers of the kidney and urinary tract in patients on dialysis for end-stage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand.
|
J Am Soc Nephrol
|
2003
|
1.84
|
|
11
|
The pattern of excess cancer in dialysis and transplantation.
|
Nephrol Dial Transplant
|
2009
|
1.48
|
|
12
|
The heritability of mammographically dense and nondense breast tissue.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.35
|
|
13
|
Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
1.30
|
|
14
|
Population-based estimate of the contribution of TP53 mutations to subgroups of early-onset breast cancer: Australian Breast Cancer Family Study.
|
Cancer Res
|
2010
|
1.26
|
|
15
|
Immunosuppression and other risk factors for early and late non-Hodgkin lymphoma after kidney transplantation.
|
Blood
|
2009
|
1.23
|
|
16
|
The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
1.21
|
|
17
|
Prognosis of premenopausal breast cancer and childbirth prior to diagnosis.
|
J Clin Oncol
|
2004
|
1.20
|
|
18
|
Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study.
|
BMJ
|
2010
|
1.18
|
|
19
|
Is there a positive association between mammographic density and bone mineral density?
|
Breast Cancer Res
|
2006
|
1.17
|
|
20
|
Oral contraceptive use and risk of early-onset breast cancer in carriers and noncarriers of BRCA1 and BRCA2 mutations.
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.16
|
|
21
|
The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer.
|
Pharmacogenetics
|
2002
|
1.10
|
|
22
|
ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.
|
J Natl Cancer Inst
|
2003
|
1.10
|
|
23
|
Fuhrman grading is not appropriate for chromophobe renal cell carcinoma.
|
Am J Surg Pathol
|
2007
|
1.10
|
|
24
|
Foods, nutrients and prostate cancer.
|
Cancer Causes Control
|
2004
|
1.09
|
|
25
|
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
|
Cancer Epidemiol Biomarkers Prev
|
2006
|
1.07
|
|
26
|
Regressive logistic and proportional hazards disease models for within-family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer.
|
Genet Epidemiol
|
2003
|
1.05
|
|
27
|
Cutaneous melanoma is related to immune suppression in kidney transplant recipients.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.05
|
|
28
|
Is there overlap between the genetic determinants of mammographic density and bone mineral density?
|
Cancer Epidemiol Biomarkers Prev
|
2005
|
1.01
|
|
29
|
Early growth, adult body size and prostate cancer risk.
|
Int J Cancer
|
2003
|
0.99
|
|
30
|
The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
|
Cancer Epidemiol Biomarkers Prev
|
2002
|
0.94
|
|
31
|
Uptake of offer to receive genetic information about BRCA1 and BRCA2 mutations in an Australian population-based study.
|
Cancer Epidemiol Biomarkers Prev
|
2004
|
0.94
|
|
32
|
Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.
|
Nephrology (Carlton)
|
2007
|
0.93
|
|
33
|
Predictors of mammographic density: insights gained from a novel regression analysis of a twin study.
|
Cancer Epidemiol Biomarkers Prev
|
2008
|
0.92
|
|
34
|
Immunosuppression and other risk factors for lip cancer after kidney transplantation.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
0.92
|
|
35
|
Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma.
|
Am J Surg Pathol
|
2006
|
0.90
|
|
36
|
An international case-control study of maternal diet during pregnancy and childhood brain tumor risk: a histology-specific analysis by food group.
|
Ann Epidemiol
|
2009
|
0.89
|
|
37
|
The HER2 I655V polymorphism and risk of breast cancer in women < age 40 years.
|
Cancer Epidemiol Biomarkers Prev
|
2003
|
0.88
|
|
38
|
Is MSH2 a breast cancer susceptibility gene?
|
Fam Cancer
|
2007
|
0.87
|
|
39
|
A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
|
Cancer Epidemiol Biomarkers Prev
|
2007
|
0.87
|
|
40
|
The incidence of treated end-stage renal disease in New Zealand Maori and Pacific Island people and in Indigenous Australians.
|
Nephrol Dial Transplant
|
2004
|
0.87
|
|
41
|
Prohibitin 3' untranslated region polymorphism and breast cancer risk in Australian women.
|
Lancet
|
2002
|
0.87
|
|
42
|
Chromosome 14q LOH in localized clear cell renal cell carcinoma.
|
J Pathol
|
2002
|
0.86
|
|
43
|
Incidence of end-stage renal disease in overseas-born, compared with Australian-born, non-indigenous Australians.
|
Nephrology (Carlton)
|
2004
|
0.85
|
|
44
|
Increased incidence of squamous cell carcinoma of eye after kidney transplantation.
|
J Natl Cancer Inst
|
2007
|
0.84
|
|
45
|
Prognostic importance of tumor size for localized conventional (clear cell) renal cell carcinoma: assessment of TNM T1 and T2 tumor categories and comparison with other prognostic parameters.
|
Cancer
|
2002
|
0.84
|
|
46
|
No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer.
|
Breast Cancer Res
|
2002
|
0.83
|
|
47
|
A protein-truncating mutation in CYP17A1 in three sisters with early-onset breast cancer.
|
Hum Mutat
|
2005
|
0.81
|
|
48
|
Is BRCA2 c.9079 G>A a predisposing variant for early onset breast cancer?
|
Breast Cancer Res Treat
|
2007
|
0.79
|
|
49
|
The enigma of hypertensive ESRD: observations on incidence and trends in 18 European, Canadian, and Asian-Pacific populations, 1998 to 2002.
|
Am J Kidney Dis
|
2006
|
0.79
|
|
50
|
CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study.
|
Breast Cancer Res
|
2005
|
0.79
|
|
51
|
Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.
|
Nephrology (Carlton)
|
2004
|
0.77
|
|
52
|
The evolution of collagen expression in sarcomatoid renal cell carcinoma.
|
Hum Pathol
|
2007
|
0.75
|